Dimerix Limited (DXB.AX)
AUD 0.42
(6.33%)
AUD 0.42
(6.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -24.95 Million AUD | -10.04% |
| 2023 | -22.68 Million AUD | -34.68% |
| 2022 | -16.47 Million AUD | -55.32% |
| 2021 | -10.02 Million AUD | -57.62% |
| 2020 | -6.81 Million AUD | -59.51% |
| 2019 | -4.31 Million AUD | -4.1% |
| 2018 | -4.13 Million AUD | -79.9% |
| 2017 | -2.29 Million AUD | -22.44% |
| 2016 | -1.27 Million AUD | -225.9% |
| 2015 | -678.52 Thousand AUD | 1.85% |
| 2014 | - AUD | -28.02% |
| 2013 | 14.62 Thousand AUD | -10.44% |
| 2012 | -386.07 Thousand AUD | -3.89% |
| 2011 | -401.81 Thousand AUD | 0.25% |
| 2010 | -346.09 Thousand AUD | 21.39% |
| 2009 | -512.42 Thousand AUD | 57.07% |
| 2008 | -2.19 Million AUD | 36.66% |
| 2007 | -1.88 Million AUD | 37.54% |
| 2006 | -11.15 Million AUD | -522.73% |
| 2005 | -484.41 Thousand AUD | -4.4% |
| 2004 | -563.58 Thousand AUD | 40.36% |
| 2003 | -777.02 Thousand AUD | -28.17% |
| 2002 | -570.75 Thousand AUD | 85.09% |
| 2001 | -4 Million AUD | -699.61% |
| 2000 | -133.71 Thousand AUD | -145.41% |
| 1999 | 1.12 Million AUD | 59.22% |
| 1998 | 703.97 Thousand AUD | 765.92% |
| 1997 | -105.71 Thousand AUD | -20.61% |
| 1996 | -87.65 Thousand AUD | 12.35% |
| 1995 | -100 Thousand AUD | 9.09% |
| 1994 | -110 Thousand AUD | -175.0% |
| 1993 | -40 Thousand AUD | -2100.0% |
| 1992 | 2000.00 AUD | 100.36% |
| 1991 | -554 Thousand AUD | -369.49% |
| 1990 | -118 Thousand AUD | -173.29% |
| 1989 | 161 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -10.63% |
| 2024 Q4 | -10.36 Million AUD | 0.0% |
| 2024 Q2 | -6.7 Million AUD | 0.0% |
| 2023 FY | - AUD | -34.68% |
| 2023 Q2 | -9.63 Million AUD | 0.0% |
| 2023 Q4 | -4.2 Million AUD | 0.0% |
| 2022 Q4 | -4.02 Million AUD | 0.0% |
| 2022 Q2 | -6.46 Million AUD | 0.0% |
| 2022 FY | - AUD | -55.32% |
| 2021 Q4 | -2.21 Million AUD | 0.0% |
| 2021 FY | - AUD | -57.62% |
| 2021 Q2 | -4.38 Million AUD | 0.0% |
| 2020 Q2 | -3.24 Million AUD | 0.0% |
| 2020 FY | - AUD | -59.51% |
| 2020 Q4 | -1.33 Million AUD | 0.0% |
| 2019 Q2 | -1.75 Million AUD | 0.0% |
| 2019 FY | - AUD | -4.1% |
| 2019 Q4 | -1.12 Million AUD | 0.0% |
| 2018 FY | - AUD | -79.9% |
| 2018 Q4 | -1.45 Million AUD | 0.0% |
| 2018 Q2 | -1.86 Million AUD | 0.0% |
| 2017 Q2 | -1.11 Million AUD | 0.0% |
| 2017 Q4 | -638.55 Thousand AUD | 0.0% |
| 2017 FY | - AUD | -22.44% |
| 2016 Q4 | -479.7 Thousand AUD | 0.0% |
| 2016 FY | - AUD | -225.9% |
| 2016 Q2 | -797.97 Thousand AUD | 0.0% |
| 2015 FY | - AUD | 1.85% |
| 2015 Q1 | -131.99 Thousand AUD | 0.0% |
| 2015 Q2 | -169.88 Thousand AUD | -28.71% |
| 2015 Q3 | -169.88 Thousand AUD | 0.0% |
| 2015 Q4 | -524.03 Thousand AUD | -208.46% |
| 2014 Q4 | - AUD | 100.0% |
| 2014 FY | - AUD | -28.02% |
| 2014 Q3 | -131.99 Thousand AUD | 0.0% |
| 2014 Q2 | -131.99 Thousand AUD | -2.1% |
| 2014 Q1 | -129.27 Thousand AUD | 0.0% |
| 2013 FY | - AUD | -10.44% |
| 2013 Q4 | - AUD | 100.0% |
| 2013 Q3 | -129.27 Thousand AUD | 0.0% |
| 2013 Q1 | -96.51 Thousand AUD | 0.0% |
| 2013 Q2 | -129.27 Thousand AUD | -33.94% |
| 2012 FY | - AUD | -3.89% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 Q3 | -96.51 Thousand AUD | 0.0% |
| 2012 Q2 | -96.51 Thousand AUD | -6925.85% |
| 2012 Q1 | 1414.00 AUD | 0.0% |
| 2011 Q3 | 1414.00 AUD | 0.0% |
| 2011 Q2 | 1414.00 AUD | 101.63% |
| 2011 FY | - AUD | 0.25% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 Q1 | -86.52 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 FY | - AUD | 21.39% |
| 2010 Q3 | -86.52 Thousand AUD | 0.0% |
| 2010 Q2 | -86.52 Thousand AUD | 91.62% |
| 2010 Q1 | -1.03 Million AUD | 0.0% |
| 2009 Q1 | -752.7 Thousand AUD | 0.0% |
| 2009 Q2 | -1.03 Million AUD | -37.13% |
| 2009 FY | - AUD | 57.07% |
| 2009 Q3 | -1.03 Million AUD | 0.0% |
| 2009 Q4 | - AUD | 100.0% |
| 2008 Q1 | -471.03 Thousand AUD | 0.0% |
| 2008 Q2 | -752.7 Thousand AUD | -59.8% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 FY | - AUD | 36.66% |
| 2008 Q3 | -752.7 Thousand AUD | 0.0% |
| 2007 Q1 | -2.78 Million AUD | 0.0% |
| 2007 Q2 | -471.03 Thousand AUD | 83.11% |
| 2007 Q3 | -471.03 Thousand AUD | 0.0% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 FY | - AUD | 37.54% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q2 | -2.78 Million AUD | -932.67% |
| 2006 Q3 | -2.78 Million AUD | 0.0% |
| 2006 Q1 | -270.05 Thousand AUD | 0.0% |
| 2006 FY | - AUD | -522.73% |
| 2005 Q4 | - AUD | 100.0% |
| 2005 Q3 | -270.05 Thousand AUD | 0.0% |
| 2005 Q2 | -270.05 Thousand AUD | 5.31% |
| 2005 FY | - AUD | -4.4% |
| 2005 Q1 | -285.18 Thousand AUD | 0.0% |
| 2004 FY | - AUD | 40.36% |
| 2004 Q3 | -285.18 Thousand AUD | 0.0% |
| 2004 Q2 | -285.18 Thousand AUD | -37.73% |
| 2004 Q1 | -207.06 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | 100.0% |
| 2003 Q3 | -207.06 Thousand AUD | 0.0% |
| 2003 Q1 | -327.6 Thousand AUD | 0.0% |
| 2003 FY | - AUD | -28.17% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 Q2 | -207.06 Thousand AUD | 36.79% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 FY | - AUD | 85.09% |
| 2002 Q1 | -2.08 Million AUD | 0.0% |
| 2002 Q2 | -327.6 Thousand AUD | 84.31% |
| 2002 Q3 | -327.6 Thousand AUD | 0.0% |
| 2001 FY | - AUD | -699.61% |
| 2001 Q1 | -200.41 Thousand AUD | 0.0% |
| 2001 Q2 | -2.08 Million AUD | -941.99% |
| 2001 Q3 | -2.08 Million AUD | 0.0% |
| 2001 Q4 | - AUD | 100.0% |
| 2000 FY | - AUD | -145.41% |
| 2000 Q4 | - AUD | 100.0% |
| 2000 Q3 | -200.41 Thousand AUD | 0.0% |
| 2000 Q1 | 441.79 Thousand AUD | 0.0% |
| 2000 Q2 | -200.41 Thousand AUD | -145.36% |
| 1999 Q2 | 441.79 Thousand AUD | 35.71% |
| 1999 FY | - AUD | 59.22% |
| 1999 Q4 | - AUD | -100.0% |
| 1999 Q3 | 441.79 Thousand AUD | 0.0% |
| 1999 Q1 | 325.53 Thousand AUD | 0.0% |
| 1998 Q4 | 325.53 Thousand AUD | 0.0% |
| 1998 Q3 | 325.53 Thousand AUD | 0.0% |
| 1998 Q2 | 325.53 Thousand AUD | 628.8% |
| 1998 FY | - AUD | 765.92% |
| 1998 Q1 | -61.56 Thousand AUD | 0.0% |
| 1997 Q3 | -61.56 Thousand AUD | 0.0% |
| 1997 Q1 | -52.78 Thousand AUD | 0.0% |
| 1997 Q4 | - AUD | 100.0% |
| 1997 FY | - AUD | -20.61% |
| 1997 Q2 | -61.56 Thousand AUD | -16.62% |
| 1996 Q3 | -52.78 Thousand AUD | 0.0% |
| 1996 Q1 | -55.75 Thousand AUD | 0.0% |
| 1996 Q4 | -52.78 Thousand AUD | 0.0% |
| 1996 FY | - AUD | 12.35% |
| 1996 Q2 | -52.78 Thousand AUD | 5.31% |
| 1995 Q3 | -55.75 Thousand AUD | 0.0% |
| 1995 Q4 | -55.75 Thousand AUD | 0.0% |
| 1995 Q2 | -55.75 Thousand AUD | 9.72% |
| 1995 Q1 | -61.75 Thousand AUD | 0.0% |
| 1995 FY | - AUD | 9.09% |
| 1994 Q2 | -61.75 Thousand AUD | -135.24% |
| 1994 Q1 | -26.25 Thousand AUD | 0.0% |
| 1994 Q4 | -61.75 Thousand AUD | 0.0% |
| 1994 FY | - AUD | -175.0% |
| 1994 Q3 | -61.75 Thousand AUD | 0.0% |
| 1993 Q2 | -26.25 Thousand AUD | -10600.0% |
| 1993 Q4 | -26.25 Thousand AUD | 0.0% |
| 1993 FY | - AUD | -2100.0% |
| 1993 Q3 | -26.25 Thousand AUD | 0.0% |
| 1993 Q1 | 250.00 AUD | 0.0% |
| 1992 FY | - AUD | 100.36% |
| 1992 Q1 | -224.5 Thousand AUD | 0.0% |
| 1992 Q2 | 250.00 AUD | 100.11% |
| 1992 Q4 | 250.00 AUD | 0.0% |
| 1992 Q3 | 250.00 AUD | 0.0% |
| 1991 Q3 | -224.5 Thousand AUD | 0.0% |
| 1991 Q4 | -224.5 Thousand AUD | 0.0% |
| 1991 Q1 | -59.25 Thousand AUD | 0.0% |
| 1991 Q2 | -224.5 Thousand AUD | -278.9% |
| 1991 FY | - AUD | -369.49% |
| 1990 Q2 | -59.25 Thousand AUD | -194.42% |
| 1990 Q3 | -59.25 Thousand AUD | 0.0% |
| 1990 Q4 | -59.25 Thousand AUD | 0.0% |
| 1990 FY | - AUD | -173.29% |
| 1990 Q1 | 62.75 Thousand AUD | 0.0% |
| 1989 Q2 | 62.75 Thousand AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| 1989 Q3 | 62.75 Thousand AUD | 0.0% |
| 1989 Q4 | 62.75 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdAlta Limited | -5.3 Million AUD | -370.676% |
| Biome Australia Limited | -1.57 Million AUD | -1481.406% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 44.996% |
| Biotron Limited | -5.04 Million AUD | -395.204% |
| Acrux Limited | -7.93 Million AUD | -214.696% |
| Alterity Therapeutics Limited | -19.57 Million AUD | -27.524% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | -79.308% |
| BTC Health Limited | 1.05 Million AUD | 2465.096% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -120.876% |
| CSL Limited | 4.73 Billion AUD | 100.527% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 44.099% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 148.124% |
| Immutep Limited | -42.87 Million AUD | 41.788% |
| Memphasys Limited | -3.3 Million AUD | -654.554% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 112.525% |
| Noxopharm Limited | -5.94 Million AUD | -319.79% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -247.336% |
| Race Oncology Limited | -14.2 Million AUD | -75.723% |
| Starpharma Holdings Limited | -12.57 Million AUD | -98.446% |
| Tissue Repair Ltd | -5.77 Million AUD | -332.183% |
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 340.553% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -1613.405% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -738.946% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 31.51% |
| Patrys Limited | -3.49 Million AUD | -614.704% |
| Orthocell Limited | -11.68 Million AUD | -113.666% |
| Imugene Limited | -147.97 Million AUD | 83.134% |
| PYC Therapeutics Limited | -38.11 Million AUD | 34.522% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -216.439% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -150.835% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -182.555% |
| Nanollose Limited | -1.14 Million AUD | -2074.277% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -3364.343% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -1289.454% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -447.385% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -785.646% |
| Nyrada Inc. | -4.59 Million AUD | -443.026% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 208.676% |
| PharmAust Limited | -9.45 Million AUD | -164.064% |
| Hexima Limited | -995.54 Thousand AUD | -2407.029% |
| AnteoTech Limited | -11.57 Million AUD | -115.7% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 61.328% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | -16.879% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -669.729% |
| Actinogen Medical Limited | -12.92 Million AUD | -93.16% |
| Immuron Limited | -6.19 Million AUD | -303.054% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -1215.275% |